ARID1A and breast carcinoma: To assess a potential role of ARID1A in the radiation resistance conferred by HuR, we downregulated ARID1A in a panel of human breast cancer cell lines—MDA-MB-231, MDA-MB-468, and SUM159PT—and assessed their clonogenic survival potential.